Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteosarcoma in adults. One institution's experience.

R D Siegel1, L M Ryan, K H Antman

  • 1Division of Medicine, Dana Farber Cancer Institute, Harvard Medical School.

Clinical Orthopaedics and Related Research
|March 1, 1989
PubMed
Summary

Adjuvant chemotherapy after complete resection of adult skeletal sarcomas shows promising results, with four of six patients remaining disease-free long-term. Adults tolerate chemotherapy well, supporting their inclusion in future adjuvant clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alcohol fuels from biomass.

Environmental science & technology·2012
Same author

Purine receptors modulate chondrocyte extracellular inorganic pyrophosphate production.

Osteoarthritis and cartilage·2010
Same author

Mouse allergen exposure, wheeze and atopy in the first seven years of life.

Allergy·2008
Same author

Residual-based diagnostics for structural equation models.

Biometrics·2008
Same author

Modeling particle exposure in U.S. trucking terminals.

Environmental science & technology·2006
Same author

Cementum and dentin in hypophosphatasia.

Journal of dental research·2005

Area of Science:

  • Oncology
  • Orthopedic Surgery
  • Medical Oncology

Background:

  • Skeletal sarcomas are rare tumors affecting adults.
  • Treatment strategies for adult skeletal sarcomas require further investigation, particularly regarding adjuvant therapies.

Purpose of the Study:

  • To evaluate the efficacy of adjuvant chemotherapy in adult patients with skeletal sarcomas.
  • To assess the tolerance of adult patients to chemotherapy.

Main Methods:

  • Retrospective review of 26 patients referred to an adult sarcoma clinic between 1979 and 1986.
  • Analysis of treatment outcomes, including complete resection and adjuvant chemotherapy, and disease-free survival rates.

Main Results:

  • Twenty-two patients had confirmed diagnoses, with a median age of 37.

Related Experiment Videos

  • Seven of twelve patients with central skeletal primaries had metastatic or unresectable disease.
  • Four of six patients receiving complete resection plus adjuvant chemotherapy remained continuously disease-free for over 25 months; one of eight patients with complete resection alone remained disease-free for over 31 months.

    • Conclusions:

    • Adults with skeletal sarcomas tolerate adjuvant chemotherapy well.
    • Adjuvant chemotherapy should be considered for adult patients with skeletal sarcomas, and they are suitable candidates for clinical trials.
    • Alternative treatment approaches may be necessary for patients with advanced-stage, poor-prognosis lesions.